Pembrolizumab Plus Concurrent Chemoradiotherapy Versus Placebo Plus Concurrent Chemoradiotherapy in Patients with Locally Advanced Squamous Cell Carcinoma of the Head and Neck (KEYNOTE-412): a Randomised, Double-Blind, Phase 3 Trial
The Lancet Oncology（2024）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined